Rick Doblin Portrait photo, founder and current president of MAPS - Multidisciplinary Association for Psychedelic Studies
MAPS bulletin - volume xvii - number 2 - Autumn 2007
< Return to Bulletin Archive Index

Letter From Rick Doblin, MAPS President

askmaps@maps.org

MAPS' focus on psychedelic and medical marijuana research studies, politics, organization-building and fundraising occupy almost all my working hours. Yet what initially motivated me to invest my life energies into this work were my personal psychedelic and marijuana experiences, and those of others who shared their stories with me.

It's these intensely personal narratives that can get lost in the details of this research project, that regulatory hurdle, this media article, that donation, each small step toward our larger goal of building a society mature enough to integrate psychedelics and marijuana rather than prohibit and repress them.

This special issue of the MAPS Bulletin on psychedelics and self-discovery is edited by Jag Davies and Sarah Hufford. MAPS' increasing use of email updates and our website to communicate about our work in detail and on a timely basis creates this opportunity for us to take a short hiatus from using the Bulletin for reports about MAPS' growing number of promising research and educational projects.This issue is an effort to bring to the foreground the experiences that often remain in the background of MAPS' work, to look in more depth at what lies beneath the surface of all our efforts.

I'm writing now after returning from Israel. I traveled there with my family this time, so my brother, my wife and I could show our three children and nephew their ancestral roots. We went on a lengthy search under the blazing sun in Jerusalem, looking for the grave of my great-great grandmother. She was buried there exactly 100 years ago, in 1907. She was the first of our relatives in modern times to move there, which she did alone, leaving her grown children behind. After finally locating her grave on the Mt. of Olives, where Jews are traditionally buried in expectation of being first in line for the resurrection, I couldn't help but wonder what she would think about MAPS' Israeli psychedelic and marijuana projects. After all, I can't quite see the point in trying to be first in line after the resurrection.

While in Israel, I worked to prepare for the enrollment of the first subject in MAPS' MDMA/PTSD study. I also laid the groundwork for MAPS' first Israeli medical marijuana projects. Along with Philippe Lucas, founder of the Vancouver Island Compassion Society (VICS), who MAPS brought to Israel as an expert consultant, I met with the Israeli Ministry of Health (MOH) official considering whether to license a non-profit medical marijuana production facility. Joining us were an Israeli MD with expertise in herbal medicines (especially the pomegranate) and several Israeli medical marijuana advocates. The facility is providing marijuana for sale to a limited number of MOH-approved patients, to keep them from having to obtain black market supplies.

I assume my great-great grandmother would initially be perplexed and inclined to disapprove of my work. Yet, I think she would come to understand and support our efforts to provide medicines and healing to those in need. What might give her pause is our broader struggle to help people experience the underlying sense of connection and meaning provided by the mystical experience, which psychedelics can catalyze. Since she had some sort of spiritual yearning, I hope that she'd see this aspect of our work as an antidote to fundamentalism, fostering a more universal spirituality that nevertheless embraces the unique particularities of religions.

The need for touchstones between religions, and for MDMA/PTSD research, was made vivid as my family and I traveled through areas of Israel that were evacuated last year during the war. One day, we walked throughout the Old City of Jerusalem, commenting on the relaxed atmosphere. The very next morning, a running gun battle broke out in the Christian Quarter, where we had been walking so shortly before. A Palestinian jumped an Israeli guard, took his gun, shot him in the shoulder, ran, and was killed by another Israeli guard who chased him. Ten bystanders were hurt, some from ricocheted bullets. It's in large part to provide antidotes to and prevention of these worldly, destructive non-psychedelic moments, that motivate me now to continue MAPS' work, inspired and empowered by the sorts of experiences presented in this special issue.

- Rick Doblin, Ph.D., MAPS President

 
< Return to Table of Contents: - Autumn 2007 "Psychedelics and Self Discovery"
 
Bulletin Archive Index
'
Winter 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine